Cambium Bio Ltd ASX: CMB Share Price & Review

CMB Overview

CMB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About CMB

Website

N/A

Telephone

61.13.0099.5098

Address

16 Goodhope Street Paddington, New South Wales (NSW) 2021

Description

Cambium Bio Ltd. engages in the development and commercialization of regenerative therapies derived from novel processed human platelets. The company is headquartered in Paddington, Australia.

CMB Price Chart

Key Stats

Market Cap

AU$4.89M

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.3 - 1.6

Trade Value (12mth)

AU$874.00

1 week

1.22%

1 month

3.75%

YTD

-17%

1 year

-48.13%

All time high

64.51

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

HALO Sector

Healthcare

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

CMB Announcements

Latest Announcements

Date	Announcements
19 July 24	Change in substantial holding × Change in substantial holding
19 July 24	Cambium Bio Ltd - Change in substantial holding (CMB-AU) × Cambium Bio Ltd - Change in substantial holding (CMB-AU)
12 July 24	Completion of Share Consolidation × Completion of Share Consolidation
12 July 24	Change of Directors Interest × Change of Directors Interest
12 July 24	Cambium Bio Ltd - Completion of Share Consolidation (CMB-AU) × Cambium Bio Ltd - Completion of Share Consolidation (CMB-AU)
12 July 24	Cambium Bio Ltd - Change of Directors Interest (CMB-AU) × Cambium Bio Ltd - Change of Directors Interest (CMB-AU)
09 July 24	Notification of cessation of securities - CMB × Notification of cessation of securities - CMB
04 July 24	Change in substantial holding × Change in substantial holding
02 July 24	Becoming a substantial holder-Apex × Becoming a substantial holder-Apex
02 July 24	Becoming a substantial holder-Treasure × Becoming a substantial holder-Treasure
02 July 24	Change in substantial holding-Apex × Change in substantial holding-Apex
02 July 24	Change in substantial holding-Treasure × Change in substantial holding-Treasure
01 July 24	Change of Director's Interest Notice × Change of Director's Interest Notice
28 June 24	Application for quotation of securities - CMB × Application for quotation of securities - CMB
28 June 24	Placement Shares Cleansing Notice × Placement Shares Cleansing Notice
25 June 24	Results of Meeting × Results of Meeting
13 June 24	Correction to Notice of General Meeting × Correction to Notice of General Meeting
23 May 24	Notice of General Meeting/Proxy Form × Notice of General Meeting/Proxy Form
23 May 24	Letter to Shareholders × Letter to Shareholders
23 May 24	Consolidation/Split - CMB × Consolidation/Split - CMB
23 May 24	Notice of Share Consolidation × Notice of Share Consolidation
14 May 24	Becoming a substantial holder - ZYBT × Becoming a substantial holder - ZYBT
14 May 24	Becoming a substantial holder - Cyntec × Becoming a substantial holder - Cyntec
01 May 24	Response to ASX Aware Query × Response to ASX Aware Query
30 April 24	Quarterly Activities/Appendix 4C Cash Flow Report × Quarterly Activities/Appendix 4C Cash Flow Report

Per Share Records

Historical data

Forecast data

	AUD	2021	2022	2023
Per Share, Growth & Valuations
EPS (Basic)	$	N/A	N/A	N/A
EPS (Fully Diluted)	$	N/A	N/A	N/A
Growth	%	N/A	N/A	N/A
PE	X	N/A	N/A	N/A
EV/EBITDA	X	N/A	N/A	N/A
CFPS	$	N/A	N/A	N/A
FCFPS	$	N/A	N/A	N/A
Growth	%	N/A	N/A	N/A
Yield	%	N/A	N/A	N/A
DPS	$	N/A	N/A	N/A
Growth	%	N/A	N/A	N/A
Yield	%	N/A	N/A	N/A
Payout Ratio	%	N/A	N/A	N/A
BPS	$	N/A	N/A	N/A
BPS (Tangible)	$	N/A	N/A	N/A
Growth	%	N/A	N/A	N/A
Shares Outstanding
Diluted	m	N/A	N/A	N/A
Basic	m	N/A	N/A	N/A

Financial Records

Historical data

Forecast data

	AUD	2021	2022	2023
Income Statement
Sales	$m	N/A	N/A	N/A
Growth	%	N/A	N/A	N/A
Selling & General Expenses	$m	N/A	N/A	N/A
Gross Income	$m	N/A	N/A	N/A
Growth	%	N/A	N/A	N/A
Margin	%	N/A	N/A	N/A
Cost of Goods Sold to Sales	%	N/A	N/A	N/A
EBITDA	$m	N/A	N/A	N/A
Growth	%	N/A	N/A	N/A
Margin	%	N/A	N/A	N/A
Depreciation & Amortisation	$m	N/A	N/A	N/A
EBIT	$m	N/A	N/A	N/A
Growth	%	N/A	N/A	N/A
Margin	%	N/A	N/A	N/A
Pretax Income	$m	N/A	N/A	N/A
Income Taxes	$m	N/A	N/A	N/A
Net Income	$m	N/A	N/A	N/A
Growth	%	N/A	N/A	N/A
Margin	%	N/A	N/A	N/A
Cash Flow Statement
Net Operating Cash Flow	$m	N/A	N/A	N/A
Capital Expenditures	$m	N/A	N/A	N/A
Net Investing Cash Flow	$m	N/A	N/A	N/A
Net Financing Cash Flow	$m	N/A	N/A	N/A
Free Cash Flow	$m	N/A	N/A	N/A
Growth	%	N/A	N/A	N/A
Margin	%	N/A	N/A	N/A
Franking Balance	$m	N/A	N/A	N/A
Balance Sheet
Cash & Short-Term Investments	$m	N/A	N/A	N/A
Total Assets	$m	N/A	N/A	N/A
Long Term Debt	$m	N/A	N/A	N/A
Net Debt	$m	N/A	N/A	N/A
Total Liabilities	$m	N/A	N/A	N/A
Equity	$m	N/A	N/A	N/A
Invested Capital		N/A	N/A	N/A
Growth	%	N/A	N/A	N/A
Return Ratios
Return on Assets	%	N/A	N/A	N/A
Return on Equity	%	N/A	N/A	N/A
Return on Total Capital	%	N/A	N/A	N/A
Return on Invested Capital	%	N/A	N/A	N/A
Cash Flow Return on Invested Capital	%	N/A	N/A	N/A

Ratios Records

Historical data

Forecast data

	AUD	2021	2022	2023
Leverage
Interest Cover	X	N/A	N/A	N/A
Debt to EBITDA	X	N/A	N/A	N/A
Net Debt to Equity	%	N/A	N/A	N/A
Liquidity
Current Ratio	X	N/A	N/A	N/A
Quick Ratio	X	N/A	N/A	N/A
Cash & ST Inv/Current Assets	%	N/A	N/A	N/A
CFO/Current Liabilities	%	N/A	N/A	N/A
Balance Sheet Efficiency
Receivables Turnover	X	N/A	N/A	N/A
Inventory Turnover	X	N/A	N/A	N/A
Working Capital Turnover	X	N/A	N/A	N/A
Payables Turnover	X	N/A	N/A	N/A
Asset Turnover	X	N/A	N/A	N/A
Du Pont
Asset Turnover	X	N/A	N/A	N/A
x Pretax Margin	%	N/A	N/A	N/A
= Pretax Return on Assets	%	N/A	N/A	N/A
x Tax Rate Complement (1-Tax Rate)	%	N/A	N/A	N/A
Return on Assets	%	N/A	N/A	N/A
x Equity Multiplier (Assets/Equity)	%	N/A	N/A	N/A
Return on Equity	%	N/A	N/A	N/A
x Earnings Retention (1-Payout)	%	N/A	N/A	N/A
= Reinvestment Rate (%)	%	N/A	N/A	N/A
Operating Cycle
Days of Inventory on Hand	Days	N/A	N/A	N/A
+ Days of Sales Outstanding	Days	N/A	N/A	N/A
Operating Cycle	Days	N/A	N/A	N/A
- Days of Payables Outstanding	Days	N/A	N/A	N/A
Net Operating Cycle	Days	N/A	N/A	N/A

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Falling Divs over next 2

Values and Recommendations

Key Stats

Consensus Score

Recommendation

EPS 1 month Change

Quality Yield

Falling Divs over next 2

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CMB Shortsell

Frequently Asked Questions

What is the current share price of Cambium Bio Ltd (CMB:ASX)?

The current share price of Cambium Bio Ltd (CMB:ASX) is AU$0.42.

What is the 52-week high share price for Cambium Bio Ltd (CMB:ASX)?

The 52-week high share price for Cambium Bio Ltd (CMB:ASX) is AU$1.60.

What is the 52-week low share price for Cambium Bio Ltd (CMB:ASX)?

The 52-week low share price for Cambium Bio Ltd (CMB:ASX)? is AU$0.30.

What is the dividend yield for Cambium Bio Ltd (CMB:ASX)?

Cambium Bio Ltd (CMB:ASX) does not pay a dividend.

What was Cambium Bio Ltd (CMB:ASX) last dividend payment?

Cambium Bio Ltd (CMB:ASX) does not pay a dividend.

What is the franking level for Cambium Bio Ltd (CMB:ASX)?

Cambium Bio Ltd (CMB:ASX) has a franking level of 0.0%.

In which sector is Cambium Bio Ltd (CMB:ASX) classified?

Cambium Bio Ltd (CMB:ASX) is classified in the Healthcare.

The current P/E ratio for Cambium Bio Ltd (CMB:ASX) is .

Company

Important

Get the latest insights and hot tips delivered right to your inbox

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.

CMB · ASX

Cambium Bio Ltd (ASX:CMB)

AU$0.42

CMB Overview

CMB Health Scores

About CMB

CMB Price Chart

Key Stats

AU$4.89M

N/A

N/A

Dividends Overview

N/A

N/A

N/A

Market Data

Key Fundamentals

Other Data

CMB Announcements

Latest Announcements

Change in substantial holding

Cambium Bio Ltd - Change in substantial holding (CMB-AU)

Completion of Share Consolidation

Change of Directors Interest

Cambium Bio Ltd - Completion of Share Consolidation (CMB-AU)

Cambium Bio Ltd - Change of Directors Interest (CMB-AU)

Notification of cessation of securities - CMB

Change in substantial holding

Becoming a substantial holder-Apex

Becoming a substantial holder-Treasure

Change in substantial holding-Apex

Change in substantial holding-Treasure

Change of Director's Interest Notice

Application for quotation of securities - CMB

Placement Shares Cleansing Notice

Results of Meeting

Correction to Notice of General Meeting

Notice of General Meeting/Proxy Form

Letter to Shareholders

Consolidation/Split - CMB

Notice of Share Consolidation

Becoming a substantial holder - ZYBT

Becoming a substantial holder - Cyntec

Response to ASX Aware Query

Quarterly Activities/Appendix 4C Cash Flow Report

CMB Fundamentals

Per Share Records

Financial Records

Ratios Records

Dividends

Key Stats

N/A

N/A

N/A

N/A

Values and Recommendations

Key Stats

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

0.00%

0

N/A

N/A

N/A

N/A

Discover Short-sellingOpportunities

CMB Shortsell

Related Companies

Frequently Asked Questions

Company

Company

Important

Discover
Short-selling
Opportunities